The biochemistry and toxicology of benzoic acid metabolism and its relationship to the elimination of waste nitrogen
- PMID: 8127924
- DOI: 10.1016/0163-7258(93)90022-6
The biochemistry and toxicology of benzoic acid metabolism and its relationship to the elimination of waste nitrogen
Abstract
Detoxification of sodium benzoate by elimination as a conjugate with glycine, a nonessential amino acid, provides a pathway for the disposal of waste nitrogen. Since 1979, sodium benzoate has been widely used in the therapeutic regimen to combat ammonia toxicity in patients born with genetic defects in the urea cycle. Although the clinical use of benzoate is associated with improved outcome, the search for biochemical evidence in support of the rationale for benzoate therapy has produced conflicting results. This review begins with an historical account leading to elucidation of the biochemistry of benzoate detoxification and early work indicating the potential utility of the pathway for elimination of waste nitrogen. An introduction to contemporary efforts at employing benzoate to treat hyperammonemia is followed by a detailed review of studies on benzoate metabolism and resultant toxic interactions with other major metabolic pathways. With this background, the several metabolic routes by which benzoate is thought to promote the disposal of waste nitrogen are then examined, followed by a consideration of alternative mechanisms by which benzoate might combat ammonia toxicity.
Similar articles
-
Waste nitrogen excretion via amino acid acylation: benzoate and phenylacetate in lysinuric protein intolerance.Pediatr Res. 1986 Nov;20(11):1117-21. doi: 10.1203/00006450-198611000-00011. Pediatr Res. 1986. PMID: 3099249
-
Potentiation of benzoate toxicity by glyoxylate. Inhibition of pyruvate carboxylase and the urea cycle.Biochem Pharmacol. 1989 Sep 1;38(17):2919-23. doi: 10.1016/0006-2952(89)90450-4. Biochem Pharmacol. 1989. PMID: 2775312
-
Disposition of sodium benzoate in newborn infants with hyperammonemia.J Pediatr. 1983 May;102(5):785-90. doi: 10.1016/s0022-3476(83)80259-5. J Pediatr. 1983. PMID: 6842341
-
Treatment of urea cycle disorders.Enzyme. 1987;38(1-4):242-50. doi: 10.1159/000469211. Enzyme. 1987. PMID: 3326732 Review.
-
Alternative pathway therapy for urea cycle disorders.J Inherit Metab Dis. 1998;21 Suppl 1:101-11. doi: 10.1023/a:1005365825875. J Inherit Metab Dis. 1998. PMID: 9686348 Review.
Cited by
-
Pathway enrichment in genome-wide analysis of longitudinal Alzheimer's disease biomarker endophenotypes.Alzheimers Dement. 2024 Dec;20(12):8639-8650. doi: 10.1002/alz.14308. Epub 2024 Oct 23. Alzheimers Dement. 2024. PMID: 39440837 Free PMC article.
-
Regulation of glycine metabolism by the glycine cleavage system and conjugation pathway in mouse models of non-ketotic hyperglycinemia.J Inherit Metab Dis. 2020 Nov;43(6):1186-1198. doi: 10.1002/jimd.12295. Epub 2020 Aug 11. J Inherit Metab Dis. 2020. PMID: 32743799 Free PMC article.
-
Quantitative Analysis of Single and Mix Food Antiseptics Basing on SERS Spectra with PLSR Method.Nanoscale Res Lett. 2016 Dec;11(1):296. doi: 10.1186/s11671-016-1507-5. Epub 2016 Jun 14. Nanoscale Res Lett. 2016. PMID: 27299651 Free PMC article.
-
Brain Activity of Benzoate, a D-Amino Acid Oxidase Inhibitor, in Patients With Mild Cognitive Impairment in a Randomized, Double-Blind, Placebo Controlled Clinical Trial.Int J Neuropsychopharmacol. 2021 May 18;24(5):392-399. doi: 10.1093/ijnp/pyab001. Int J Neuropsychopharmacol. 2021. PMID: 33406269 Free PMC article. Clinical Trial.
-
Ag Nanorods-Oxide Hybrid Array Substrates: Synthesis, Characterization, and Applications in Surface-Enhanced Raman Scattering.Sensors (Basel). 2017 Aug 17;17(8):1895. doi: 10.3390/s17081895. Sensors (Basel). 2017. PMID: 28817107 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources